Boston Partners’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.3M Sell
2,478,866
-788,526
-24% -$4.39M 0.02% 409
2026
Q1
$12.8M Buy
3,267,392
+1,046,542
+47% +$4.65M 0.01% 417
2025
Q4
$10.1M Buy
2,220,850
+606,446
+38% +$3.11M 0.01% 426
2025
Q3
$9.9M Buy
1,614,404
+837,123
+108% +$5.3M 0.01% 416
2025
Q2
$5.04M Buy
777,281
+736,303
+1,797% +$3.97M 0.01% 442
2025
Q1
$218K Buy
40,978
+9,433
+30% +$64.4K ﹤0.01% 694
2024
Q4
$265K Buy
+31,545
New +$244K ﹤0.01% 692

Other funds holding TBI

Boston Partners's TBI Position: Q2 2026 in Review

Boston Partners reduced its Trueblue (TBI) stake by 24% in Q2 2026, selling an estimated $4.39M and leaving 2,478,866 shares worth $17.3M. The position accounts for 0.02% of the portfolio, ranked #409.

Boston Partners first reported a position in TBI in Q4 2024 and has held it in 7 quarters since. 114 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • Boston Partners held 2,478,866 shares of Trueblue worth $17.3M as of Q2 2026.
  • Boston Partners sold 788,526 Trueblue shares in Q2 2026, an estimated $4.39M.
  • Trueblue made up 0.02% of Boston Partners's portfolio in Q2 2026, its #409 holding.
  • Boston Partners first reported a position in Trueblue in Q4 2024 and has held it in 7 quarters since.
  • 114 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.